SESSION TITLE: Interventional Pulmonology Posters I
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 28, 2015 at 01:30 PM - 02:30 PM
PURPOSE: To evaluate the efficacy and safety of povidone iodine (PI) through tube thoracostomy in preventing recurrence of spontaneous pneumothorax (SP).
METHODS: Retrospective analysis of records of patients undergoing pleurodesis for SP between January 2012 and September 2014 at a tertiary care referral center. 20 ml povidone iodine 10% diluted with 80 ml of normal saline through a chest tube was the agent used to achieve pleurodesis.
RESULTS: 37 episodes of SP were managed in 34 patients; two patients had bilateral pneumothorax. There were 29 male (85.3%) and 5 female (14.7%) patients; pneumothorax was in the right side in 23 (62.2%) and in left side in 14(37.8%) of patients. Etiology was primary in 19 (51.4%) and secondary (48.6%) of patients and 16 patients gave history of smoking. Mean age of patients with primary SP was 31.33 and secondary SP was 57.52 years. Minor pain was noted after 10 procedures (27%) and one patient developed empyema (2.7%). Pleurodesis was successful in 36 of the 37 episodes (97.3%); one patient developed recurrence after 1 month, which was successfully managed with a re-pleurodesis. Mean follow up period was 14.6 months.
CONCLUSIONS: PI through tube thoracostomy is a safe and effective agent for preventing recurrence of pneumothorax.
CLINICAL IMPLICATIONS: PI is a cheap and easily available agent, its use to achieve pleurodesis effectively provides an excellent alertnative to existing sclerosing agents especially in a resource constrained country like India
DISCLOSURE: The following authors have nothing to disclose: Arjun Srinivasan, Pattabhi Raman Vallandramam, Mahadevan Sivaramakrishnan, Pavan Yadav
No Product/Research Disclosure Information